275 related articles for article (PubMed ID: 12727822)
1. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
2. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
[TBL] [Abstract][Full Text] [Related]
3. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
[TBL] [Abstract][Full Text] [Related]
4. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
Rabbani SA; Harakidas P; Bowlin T; Attardo G
Cancer Res; 1998 Aug; 58(15):3461-5. PubMed ID: 9699681
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
6. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
7. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
8. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
9. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.
Wysolmerski JJ; Dann PR; Zelazny E; Dunbar ME; Insogna KL; Guise TA; Perkins AS
J Bone Miner Res; 2002 Jul; 17(7):1164-70. PubMed ID: 12096830
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence.
Gujral A; Burton DW; Terkeltaub R; Deftos LJ
Cancer Res; 2001 Mar; 61(5):2282-8. PubMed ID: 11280799
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
Deftos LJ; Barken I; Burton DW; Hoffman RM; Geller J
Biochem Biophys Res Commun; 2005 Feb; 327(2):468-72. PubMed ID: 15629138
[TBL] [Abstract][Full Text] [Related]
16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
17. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
18. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells.
Pizzi H; Gladu J; Carpio L; Miao D; Goltzman D; Rabbani SA
Endocrinology; 2003 Mar; 144(3):858-67. PubMed ID: 12586762
[TBL] [Abstract][Full Text] [Related]
19. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
Rabbani SA; Gladu J
Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
[TBL] [Abstract][Full Text] [Related]
20. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]